Gene symbol: Bcl2l1

Also known as: Bclx; Bcl2l; bcl-X; Bcl-xl

Organism: Rattus norvegicus

Summary: Enables several functions, including GTPase binding activity; MDM2/MDM4 family protein binding activity; and cysteine-type endopeptidase inhibitor activity involved in apoptotic process. Involved in several processes, including cellular response to cytokine stimulus; cellular response to lipid; and positive regulation of transport. Located in cytosol; mitochondrial outer membrane; and presynapse. Colocalizes with clathrin-coated pit; mitochondrial membrane; and synaptic vesicle membrane. Used to study amyotrophic lateral sclerosis; artery disease (multiple); endometriosis; gastric ulcer; and impotence. Biomarker of several diseases, including acute kidney failure; brain ischemia; mental depression; ocular hypertension; and status epilepticus. Human ortholog(s) of this gene implicated in breast cancer; carcinoma (multiple); leukemia (multiple); pancreatic cancer; and stomach cancer. Orthologous to human BCL2L1 (BCL2 like 1). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 24888 Ensembl:ENSRNOG00000007946 AllianceGenome:RGD:2200


GO Annotation


Category Term ID Term description
Process GO:0000003 Reproduction
Process GO:0000302 Response to reactive oxygen species
Process GO:0001101 Response to acid chemical
Process GO:0001505 Regulation of neurotransmitter levels
Process GO:0001541 Ovarian follicle development
Process GO:0001666 Response to hypoxia
Process GO:0001701 In utero embryonic development
Process GO:0001836 Release of cytochrome c from mitochondria
Process GO:0001956 Positive regulation of neurotransmitter secretion
Process GO:0002237 Response to molecule of bacterial origin
Process GO:0002931 Response to ischemia
Process GO:0003006 Developmental process involved in reproduction
Process GO:0006140 Regulation of nucleotide metabolic process
Process GO:0006810 Transport
Process GO:0006839 Mitochondrial transport
Process GO:0006897 Endocytosis
Process GO:0006915 Apoptotic process
Process GO:0006950 Response to stress
Process GO:0006952 Defense response
Process GO:0006974 Cellular response to DNA damage stimulus
Process GO:0006979 Response to oxidative stress
Process GO:0006996 Organelle organization
Process GO:0007005 Mitochondrion organization
Process GO:0007006 Mitochondrial membrane organization
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007275 Multicellular organism development
Process GO:0007276 Gamete generation
Process GO:0007281 Germ cell development
Process GO:0007283 Spermatogenesis
Process GO:0007399 Nervous system development
Process GO:0007417 Central nervous system development
Process GO:0007420 Brain development
Process GO:0007548 Sex differentiation
Process GO:0007568 Aging
Process GO:0008219 Cell death
Process GO:0008283 Cell population proliferation
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0008406 Gonad development
Process GO:0008584 Male gonad development
Process GO:0008585 Female gonad development
Process GO:0008630 Intrinsic apoptotic signaling pathway in response to DNA damage
Process GO:0008637 Apoptotic mitochondrial changes
Process GO:0009314 Response to radiation
Process GO:0009410 Response to xenobiotic stimulus
Process GO:0009566 Fertilization
Process GO:0009605 Response to external stimulus
Process GO:0009607 Response to biotic stimulus
Process GO:0009615 Response to virus
Process GO:0009617 Response to bacterium
Process GO:0009628 Response to abiotic stimulus
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009719 Response to endogenous stimulus
Process GO:0009725 Response to hormone
Process GO:0009790 Embryo development
Process GO:0009792 Embryo development ending in birth or egg hatching
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009968 Negative regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010035 Response to inorganic substance
Process GO:0010038 Response to metal ion
Process GO:0010212 Response to ionizing radiation
Process GO:0010243 Response to organonitrogen compound
Process GO:0010288 Response to lead ion
Process GO:0010332 Response to gamma radiation
Process GO:0010466 Negative regulation of peptidase activity
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010564 Regulation of cell cycle process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010648 Negative regulation of cell communication
Process GO:0010941 Regulation of cell death
Process GO:0010942 Positive regulation of cell death
Process GO:0010951 Negative regulation of endopeptidase activity
Process GO:0012501 Programmed cell death
Process GO:0014070 Response to organic cyclic compound
Process GO:0014074 Response to purine-containing compound
Process GO:0016043 Cellular component organization
Process GO:0016192 Vesicle-mediated transport
Process GO:0016197 Endosomal transport
Process GO:0017157 Regulation of exocytosis
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019953 Sexual reproduction
Process GO:0021537 Telencephalon development
Process GO:0021543 Pallium development
Process GO:0021987 Cerebral cortex development
Process GO:0022412 Cellular process involved in reproduction in multicellular organism
Process GO:0022414 Reproductive process
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0023057 Negative regulation of signaling
Process GO:0030100 Regulation of endocytosis
Process GO:0030154 Cell differentiation
Process GO:0030162 Regulation of proteolysis
Process GO:0030808 Regulation of nucleotide biosynthetic process
Process GO:0030810 Positive regulation of nucleotide biosynthetic process
Process GO:0030900 Forebrain development
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031960 Response to corticosteroid
Process GO:0032465 Regulation of cytokinesis
Process GO:0032496 Response to lipopolysaccharide
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032504 Multicellular organism reproduction
Process GO:0032870 Cellular response to hormone stimulus
Process GO:0032879 Regulation of localization
Process GO:0032880 Regulation of protein localization
Process GO:0032989 Cellular component morphogenesis
Process GO:0032990 Cell part morphogenesis
Process GO:0033554 Cellular response to stress
Process GO:0033993 Response to lipid
Process GO:0034097 Response to cytokine
Process GO:0034612 Response to tumor necrosis factor
Process GO:0035556 Intracellular signal transduction
Process GO:0036017 Response to erythropoietin
Process GO:0036018 Cellular response to erythropoietin
Process GO:0036293 Response to decreased oxygen levels
Process GO:0036294 Cellular response to decreased oxygen levels
Process GO:0036465 Synaptic vesicle recycling
Process GO:0036466 Synaptic vesicle recycling via endosome
Process GO:0038034 Signal transduction in absence of ligand
Process GO:0040008 Regulation of growth
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042221 Response to chemical
Process GO:0042391 Regulation of membrane potential
Process GO:0042542 Response to hydrogen peroxide
Process GO:0042981 Regulation of apoptotic process
Process GO:0043009 Chordate embryonic development
Process GO:0043065 Positive regulation of apoptotic process
Process GO:0043066 Negative regulation of apoptotic process
Process GO:0043067 Regulation of programmed cell death
Process GO:0043068 Positive regulation of programmed cell death
Process GO:0043069 Negative regulation of programmed cell death
Process GO:0043086 Negative regulation of catalytic activity
Process GO:0043154 Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
Process GO:0043200 Response to amino acid
Process GO:0043207 Response to external biotic stimulus
Process GO:0043279 Response to alkaloid
Process GO:0043281 Regulation of cysteine-type endopeptidase activity involved in apoptotic process
Process GO:0043434 Response to peptide hormone
Process GO:0043523 Regulation of neuron apoptotic process
Process GO:0043524 Negative regulation of neuron apoptotic process
Process GO:0044092 Negative regulation of molecular function
Process GO:0044419 Biological process involved in interspecies interaction between organisms
Process GO:0045137 Development of primary sexual characteristics
Process GO:0045807 Positive regulation of endocytosis
Process GO:0045861 Negative regulation of proteolysis
Process GO:0045921 Positive regulation of exocytosis
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0045981 Positive regulation of nucleotide metabolic process
Process GO:0046545 Development of primary female sexual characteristics
Process GO:0046546 Development of primary male sexual characteristics
Process GO:0046660 Female sex differentiation
Process GO:0046661 Male sex differentiation
Process GO:0046683 Response to organophosphorus
Process GO:0046898 Response to cycloheximide
Process GO:0046902 Regulation of mitochondrial membrane permeability
Process GO:0046907 Intracellular transport
Process GO:0046928 Regulation of neurotransmitter secretion
Process GO:0048167 Regulation of synaptic plasticity
Process GO:0048232 Male gamete generation
Process GO:0048468 Cell development
Process GO:0048513 Animal organ development
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048545 Response to steroid hormone
Process GO:0048583 Regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0048608 Reproductive structure development
Process GO:0048609 Multicellular organismal reproductive process
Process GO:0048731 System development
Process GO:0048856 Anatomical structure development
Process GO:0048869 Cellular developmental process
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050794 Regulation of cellular process
Process GO:0050804 Modulation of chemical synaptic transmission
Process GO:0050806 Positive regulation of synaptic transmission
Process GO:0050896 Response to stimulus
Process GO:0051046 Regulation of secretion
Process GO:0051047 Positive regulation of secretion
Process GO:0051049 Regulation of transport
Process GO:0051050 Positive regulation of transport
Process GO:0051128 Regulation of cellular component organization
Process GO:0051130 Positive regulation of cellular component organization
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051172 Negative regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051179 Localization
Process GO:0051234 Establishment of localization
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051248 Negative regulation of protein metabolic process
Process GO:0051302 Regulation of cell division
Process GO:0051336 Regulation of hydrolase activity
Process GO:0051346 Negative regulation of hydrolase activity
Process GO:0051384 Response to glucocorticoid
Process GO:0051402 Neuron apoptotic process
Process GO:0051588 Regulation of neurotransmitter transport
Process GO:0051590 Positive regulation of neurotransmitter transport
Process GO:0051591 Response to cAMP
Process GO:0051602 Response to electrical stimulus
Process GO:0051607 Defense response to virus
Process GO:0051641 Cellular localization
Process GO:0051649 Establishment of localization in cell
Process GO:0051707 Response to other organism
Process GO:0051716 Cellular response to stimulus
Process GO:0051726 Regulation of cell cycle
Process GO:0051881 Regulation of mitochondrial membrane potential
Process GO:0052547 Regulation of peptidase activity
Process GO:0052548 Regulation of endopeptidase activity
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060322 Head development
Process GO:0060341 Regulation of cellular localization
Process GO:0060548 Negative regulation of cell death
Process GO:0060627 Regulation of vesicle-mediated transport
Process GO:0061024 Membrane organization
Process GO:0061458 Reproductive system development
Process GO:0062012 Regulation of small molecule metabolic process
Process GO:0062013 Positive regulation of small molecule metabolic process
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070482 Response to oxygen levels
Process GO:0070555 Response to interleukin-1
Process GO:0070584 Mitochondrion morphogenesis
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0070997 Neuron death
Process GO:0071214 Cellular response to abiotic stimulus
Process GO:0071229 Cellular response to acid chemical
Process GO:0071230 Cellular response to amino acid stimulus
Process GO:0071310 Cellular response to organic substance
Process GO:0071312 Cellular response to alkaloid
Process GO:0071320 Cellular response to cAMP
Process GO:0071345 Cellular response to cytokine stimulus
Process GO:0071347 Cellular response to interleukin-1
Process GO:0071356 Cellular response to tumor necrosis factor
Process GO:0071375 Cellular response to peptide hormone stimulus
Process GO:0071383 Cellular response to steroid hormone stimulus
Process GO:0071384 Cellular response to corticosteroid stimulus
Process GO:0071385 Cellular response to glucocorticoid stimulus
Process GO:0071396 Cellular response to lipid
Process GO:0071407 Cellular response to organic cyclic compound
Process GO:0071417 Cellular response to organonitrogen compound
Process GO:0071453 Cellular response to oxygen levels
Process GO:0071456 Cellular response to hypoxia
Process GO:0071466 Cellular response to xenobiotic stimulus
Process GO:0071478 Cellular response to radiation
Process GO:0071479 Cellular response to ionizing radiation
Process GO:0071480 Cellular response to gamma radiation
Process GO:0071495 Cellular response to endogenous stimulus
Process GO:0071548 Response to dexamethasone
Process GO:0071549 Cellular response to dexamethasone stimulus
Process GO:0071839 Apoptotic process in bone marrow cell
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0080090 Regulation of primary metabolic process
Process GO:0080134 Regulation of response to stress
Process GO:0080135 Regulation of cellular response to stress
Process GO:0090559 Regulation of membrane permeability
Process GO:0097190 Apoptotic signaling pathway
Process GO:0097191 Extrinsic apoptotic signaling pathway
Process GO:0097192 Extrinsic apoptotic signaling pathway in absence of ligand
Process GO:0097193 Intrinsic apoptotic signaling pathway
Process GO:0097284 Hepatocyte apoptotic process
Process GO:0097305 Response to alcohol
Process GO:0098542 Defense response to other organism
Process GO:0099003 Vesicle-mediated transport in synapse
Process GO:0099177 Regulation of trans-synaptic signaling
Process GO:0099504 Synaptic vesicle cycle
Process GO:0099532 Synaptic vesicle endosomal processing
Process GO:0104004 Cellular response to environmental stimulus
Process GO:0140546 Defense response to symbiont
Process GO:1900117 Regulation of execution phase of apoptosis
Process GO:1900118 Negative regulation of execution phase of apoptosis
Process GO:1900242 Regulation of synaptic vesicle endocytosis
Process GO:1900244 Positive regulation of synaptic vesicle endocytosis
Process GO:1900371 Regulation of purine nucleotide biosynthetic process
Process GO:1900373 Positive regulation of purine nucleotide biosynthetic process
Process GO:1900452 Regulation of long-term synaptic depression
Process GO:1900542 Regulation of purine nucleotide metabolic process
Process GO:1900544 Positive regulation of purine nucleotide metabolic process
Process GO:1901214 Regulation of neuron death
Process GO:1901215 Negative regulation of neuron death
Process GO:1901652 Response to peptide
Process GO:1901653 Cellular response to peptide
Process GO:1901654 Response to ketone
Process GO:1901655 Cellular response to ketone
Process GO:1901698 Response to nitrogen compound
Process GO:1901699 Cellular response to nitrogen compound
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1902041 Regulation of extrinsic apoptotic signaling pathway via death domain receptors
Process GO:1902042 Negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
Process GO:1902229 Regulation of intrinsic apoptotic signaling pathway in response to DNA damage
Process GO:1902230 Negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage
Process GO:1902235 Regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway
Process GO:1902236 Negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902532 Negative regulation of intracellular signal transduction
Process GO:1903076 Regulation of protein localization to plasma membrane
Process GO:1903077 Negative regulation of protein localization to plasma membrane
Process GO:1903305 Regulation of regulated secretory pathway
Process GO:1903307 Positive regulation of regulated secretory pathway
Process GO:1903421 Regulation of synaptic vesicle recycling
Process GO:1903423 Positive regulation of synaptic vesicle recycling
Process GO:1903530 Regulation of secretion by cell
Process GO:1903532 Positive regulation of secretion by cell
Process GO:1903573 Negative regulation of response to endoplasmic reticulum stress
Process GO:1903578 Regulation of ATP metabolic process
Process GO:1903580 Positive regulation of ATP metabolic process
Process GO:1903828 Negative regulation of protein localization
Process GO:1904019 Epithelial cell apoptotic process
Process GO:1904375 Regulation of protein localization to cell periphery
Process GO:1904376 Negative regulation of protein localization to cell periphery
Process GO:1904578 Response to thapsigargin
Process GO:1904579 Cellular response to thapsigargin
Process GO:1905217 Response to astaxanthin
Process GO:1905218 Cellular response to astaxanthin
Process GO:1905475 Regulation of protein localization to membrane
Process GO:1905476 Negative regulation of protein localization to membrane
Process GO:1905897 Regulation of response to endoplasmic reticulum stress
Process GO:1990637 Response to prolactin
Process GO:1990646 Cellular response to prolactin
Process GO:2000116 Regulation of cysteine-type endopeptidase activity
Process GO:2000117 Negative regulation of cysteine-type endopeptidase activity
Process GO:2000300 Regulation of synaptic vesicle exocytosis
Process GO:2000302 Positive regulation of synaptic vesicle exocytosis
Process GO:2000807 Regulation of synaptic vesicle clustering
Process GO:2000809 Positive regulation of synaptic vesicle clustering
Process GO:2001020 Regulation of response to DNA damage stimulus
Process GO:2001021 Negative regulation of response to DNA damage stimulus
Process GO:2001169 Regulation of ATP biosynthetic process
Process GO:2001171 Positive regulation of ATP biosynthetic process
Process GO:2001233 Regulation of apoptotic signaling pathway
Process GO:2001234 Negative regulation of apoptotic signaling pathway
Process GO:2001236 Regulation of extrinsic apoptotic signaling pathway
Process GO:2001237 Negative regulation of extrinsic apoptotic signaling pathway
Process GO:2001242 Regulation of intrinsic apoptotic signaling pathway
Process GO:2001243 Negative regulation of intrinsic apoptotic signaling pathway
Component GO:0005622 Intracellular anatomical structure
Component GO:0005634 Nucleus
Component GO:0005635 Nuclear envelope
Component GO:0005737 Cytoplasm
Component GO:0005739 Mitochondrion
Component GO:0005740 Mitochondrial envelope
Component GO:0005741 Mitochondrial outer membrane
Component GO:0005743 Mitochondrial inner membrane
Component GO:0005759 Mitochondrial matrix
Component GO:0005783 Endoplasmic reticulum
Component GO:0005813 Centrosome
Component GO:0005815 Microtubule organizing center
Component GO:0005829 Cytosol
Component GO:0005856 Cytoskeleton
Component GO:0008021 Synaptic vesicle
Component GO:0012505 Endomembrane system
Component GO:0012506 Vesicle membrane
Component GO:0015630 Microtubule cytoskeleton
Component GO:0016020 Membrane
Component GO:0016021 Integral component of membrane
Component GO:0019866 Organelle inner membrane
Component GO:0019867 Outer membrane
Component GO:0030054 Cell junction
Component GO:0030133 Transport vesicle
Component GO:0030658 Transport vesicle membrane
Component GO:0030659 Cytoplasmic vesicle membrane
Component GO:0030672 Synaptic vesicle membrane
Component GO:0031090 Organelle membrane
Component GO:0031224 Intrinsic component of membrane
Component GO:0031410 Cytoplasmic vesicle
Component GO:0031965 Nuclear membrane
Component GO:0031966 Mitochondrial membrane
Component GO:0031967 Organelle envelope
Component GO:0031968 Organelle outer membrane
Component GO:0031974 Membrane-enclosed lumen
Component GO:0031975 Envelope
Component GO:0031982 Vesicle
Component GO:0032991 Protein-containing complex
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043228 Non-membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0043232 Intracellular non-membrane-bounded organelle
Component GO:0043233 Organelle lumen
Component GO:0045202 Synapse
Component GO:0070013 Intracellular organelle lumen
Component GO:0070161 Anchoring junction
Component GO:0070382 Exocytic vesicle
Component GO:0097136 Bcl-2 family protein complex
Component GO:0097708 Intracellular vesicle
Component GO:0098588 Bounding membrane of organelle
Component GO:0098793 Presynapse
Component GO:0099501 Exocytic vesicle membrane
Component GO:0099503 Secretory vesicle
Component GO:0110165 Cellular anatomical entity
Function GO:0004857 Enzyme inhibitor activity
Function GO:0004866 Endopeptidase inhibitor activity
Function GO:0004869 Cysteine-type endopeptidase inhibitor activity
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0019899 Enzyme binding
Function GO:0019900 Kinase binding
Function GO:0019901 Protein kinase binding
Function GO:0019904 Protein domain specific binding
Function GO:0030234 Enzyme regulator activity
Function GO:0030276 Clathrin binding
Function GO:0030414 Peptidase inhibitor activity
Function GO:0042802 Identical protein binding
Function GO:0042803 Protein homodimerization activity
Function GO:0043027 Cysteine-type endopeptidase inhibitor activity involved in apoptotic process
Function GO:0043028 Cysteine-type endopeptidase regulator activity involved in apoptotic process
Function GO:0044877 Protein-containing complex binding
Function GO:0046982 Protein heterodimerization activity
Function GO:0046983 Protein dimerization activity
Function GO:0051020 GTPase binding
Function GO:0051400 BH domain binding
Function GO:0051434 BH3 domain binding
Function GO:0061134 Peptidase regulator activity
Function GO:0061135 Endopeptidase regulator activity
Function GO:0070513 Death domain binding
Function GO:0097371 MDM2/MDM4 family protein binding
Function GO:0098772 Molecular function regulator activity

Pathway annotation


Category Term ID Term description
RCTM RNO-109581 Apoptosis
RCTM RNO-109606 Intrinsic Pathway for Apoptosis
RCTM RNO-111453 BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
RCTM RNO-162582 Signal Transduction
RCTM RNO-168249 Innate Immune System
RCTM RNO-168256 Immune System
RCTM RNO-168643 Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
RCTM RNO-5357801 Programmed Cell Death
RCTM RNO-5673001 RAF/MAP kinase cascade
RCTM RNO-5683057 MAPK family signaling cascades
RCTM RNO-5684996 MAPK1/MAPK3 signaling
RCTM RNO-622312 Inflammasomes
RCTM RNO-9648002 RAS processing
RCTM RNO-844455 The NLRP1 inflammasome
WikiPathways WP319 IL-3 signaling pathway
KEGG rno01521 EGFR tyrosine kinase inhibitor resistance
KEGG rno01524 Platinum drug resistance
KEGG rno04014 Ras signaling pathway
KEGG rno04064 NF-kappa B signaling pathway
KEGG rno04115 p53 signaling pathway
KEGG rno04137 Mitophagy - animal
KEGG rno04140 Autophagy - animal
KEGG rno04151 PI3K-Akt signaling pathway
KEGG rno04210 Apoptosis
KEGG rno04215 Apoptosis - multiple species
KEGG rno04621 NOD-like receptor signaling pathway
KEGG rno04630 JAK-STAT signaling pathway
KEGG rno05012 Parkinson disease
KEGG rno05014 Amyotrophic lateral sclerosis
KEGG rno05022 Pathways of neurodegeneration - multiple diseases
KEGG rno05145 Toxoplasmosis
KEGG rno05162 Measles
KEGG rno05166 Human T-cell leukemia virus 1 infection
KEGG rno05168 Herpes simplex virus 1 infection
KEGG rno05170 Human immunodeficiency virus 1 infection
KEGG rno05200 Pathways in cancer
KEGG rno05202 Transcriptional misregulation in cancer
KEGG rno05212 Pancreatic cancer
KEGG rno05220 Chronic myeloid leukemia
KEGG rno05222 Small cell lung cancer
KEGG rno05225 Hepatocellular carcinoma
KEGG rno05417 Lipid and atherosclerosis

Expression profile of Bcl2l1 in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 10.6653198
GSM2685202 MX2 tissue: Myocardium gender: female 10.451481625
GSM2685203 MX3 tissue: Myocardium gender: female 10.6420669
GSM2685204 MX4 tissue: Myocardium gender: male 10.781507125
GSM2685205 DZ1 tissue: Myocardium gender: male 10.99218125
GSM2685206 DZ2 tissue: Myocardium gender: male 10.06164325
GSM2685207 DZ3 tissue: Myocardium gender: female 10.3304996
GSM2685208 DZ4 tissue: Myocardium gender: female 10.2906241
GSM2685209 JJ1 tissue: Myocardium gender: male 10.341118575
GSM2685210 JJ2 tissue: Myocardium gender: female 10.430425925
GSM2685211 JJ3 tissue: Myocardium gender: female 10.790457325
GSM2685212 JJ4 tissue: Myocardium gender: male 10.924390325000001
GSM2685213 NG1 tissue: Myocardium gender: male 11.068013950000001
GSM2685214 NG2 tissue: Myocardium gender: female 10.702885
GSM2685215 NG3 tissue: Myocardium gender: male 10.988661950000001
GSM2685216 NG4 tissue: Myocardium gender: female 10.7630795
GSM2685217 YL1 tissue: Myocardium gender: male 10.61924355
GSM2685218 YL2 tissue: Myocardium gender: male 10.7121034
GSM2685219 YL3 tissue: Myocardium gender: female 10.634270375
GSM2685220 YL4 tissue: Myocardium gender: female 10.608149749999999
GSM2685221 QC1 tissue: Myocardium gender: male 10.24353265
GSM2685222 QC2 tissue: Myocardium gender: male 10.741323699999999
GSM2685223 QC3 tissue: Myocardium gender: female 10.77560425
GSM2685224 QC4 tissue: Myocardium gender: female 11.07322935

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.142321792
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.05655323
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.161171947
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.143209673
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.182487595
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.053316538

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 631.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 999.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1766.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 959.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 448.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 389.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 370.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1018.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 406.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 535.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 432.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 579.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 276.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 223.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 355.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 372.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 7.636019
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 7.795357
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 7.888433
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 7.99869
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 7.972104
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 7.876866

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 48.449
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 43.854
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 52.861
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 49.165
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 50.235

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 6.293514395666667
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 6.301742309333332
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 6.6572113276666665

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 313.3
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 336.4
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 212.975
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 298.85
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 285.4
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 232.35
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 145.875
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 262.725
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 246.925
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 167.45
GSM27494 CTL_a (control, 1st replicate) 206.22500000000002
GSM27495 CTL_b (control, 2nd replicate) 175.375
GSM27496 CTL_c (control, 3rd replicate) 276.1
GSM27497 CTL_d (control, 4th replicate) 195.45
GSM27498 CTL_e (control, 5th replicate) 239.5
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 225.0
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 273.75
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 229.925
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 250.72500000000002
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 214.54999999999998
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 292.425
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 209.925
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 188.575
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 212.8
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 270.7
GSM27509 ISCH_a (ischemia, 1st replicate) 268.025
GSM27510 ISCH_b (ischemia, 2nd replicate) 248.05
GSM27511 ISCH_c (ischemia, 3rd replicate) 250.25
GSM27512 ISCH_d (ischemia, 4th replicate) 315.8
GSM27513 ISCH_e (ischemia, 5th replicate) 194.5

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 236.86666666666667
GSM30791 baseline control 02 male, 275-300g 175.36666666666667
GSM30792 baseline control 03 male, 275-300g 152.5666666666667
GSM30793 baseline control 04 male, 275-300g 168.93333333333334
GSM30794 baseline control 05 male, 275-300g 191.63333333333333
GSM30795 baseline control 06 male, 275-300g 128.5
GSM30796 baseline control 07 male, 275-300g 180.76666666666665
GSM30797 baseline control 08 male, 275-300g 151.63333333333333
GSM30798 baseline control 09 male, 275-300g 153.4333333333333
GSM30799 pain 01 178.30000000000004
GSM30800 pain 02 174.66666666666666
GSM30801 pain 03 218.9
GSM30802 pain 04 190.1
GSM30803 pain 05 178.16666666666666
GSM30804 FC 01 211.20000000000002
GSM30805 FC 02 203.80000000000004
GSM30806 FC 03 155.46666666666667
GSM30807 FC 04 159.70000000000002
GSM30808 FC 05 158.86666666666667
GSM30809 IFC 01 217.0333333333333
GSM30810 IFC 02 175.1
GSM30811 IFC 03 195.83333333333334
GSM30812 IFC 04 155.56666666666666
GSM30813 IFC 05 170.26666666666668
GSM99800 isoflurane 01 male, 275-300g 198.53333333333333
GSM99801 isoflurane 02 male, 275-300g 201.26666666666665
GSM99802 isoflurane 03 male, 275-300g 184.4666666666667
GSM99803 isoflurane 04 male, 275-300g 167.63333333333333
GSM99804 isoflurane 05 male, 275-300g 142.5

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 56.22560000000001
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 52.49133333333333
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 55.763200000000005
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 60.13616666666667
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 64.5524
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 75.3527
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 48.891333333333336
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 55.12756666666667
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 52.32826666666667

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 13.2433
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 13.1602
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 13.9147
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 13.6585
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 13.0933
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 12.7934
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 13.1959
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 12.5945
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 13.1792
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 13.1803
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 13.7913
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 13.6613
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 12.8139
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 12.7682
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 12.8874
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 12.8346

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.74161
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.859912
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.74315
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.754623
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.782868
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.735193
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.894028
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.765396
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.803088
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.785448
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.769479
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.806643
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.713912
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.802835
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.821441
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.687732
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.712412
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.741807
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.77756
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.739318
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.672864
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.873771
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.812375
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.700338
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.6666
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.644366
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.721503
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.750647
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.595092
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.731213
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.584191
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.768806
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.63078
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.788722
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.811596
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.880278
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.720199
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.764744
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.970199
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.818259
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.743133
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.7852
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.534102
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.714586
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.769996

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 454.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 474.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 507.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 521.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 584.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 569.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 515.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 543.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 484.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 779.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 542.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 528.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 528.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 613.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 658.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 442.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 573.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 482.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 476.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 458.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 500.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 731.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 658.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 601.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 599.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 472.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 608.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 543.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 641.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 618.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 616.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 660.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 598.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 596.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 636.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 430.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 10.736493
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 8.913684
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 9.935317
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 11.67769

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; 0.0
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 0.0181
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 0.0
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.343
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 0.0
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 0.0
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 0.0133
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 0.0
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 0.0
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 0.0
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 0.134
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 -0.175

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 85.45
GSM5121 Isoflurane single exposure control-2 74.69999999999999
GSM5122 Isoflurane single exposure control-3 45.95
GSM5124 Isoflurane single exposure 1 hr-1 66.65
GSM5126 Isoflurane single exposure 1 hr-2 62.375
GSM5127 Isoflurane single exposure 2 hr-1 68.425
GSM5130 Isoflurane single exposure 2 hr-2 103.025
GSM5131 Isoflurane single exposure 2 hr-3 63.25

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.693808885333333
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.7444391249999995
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 5.912921007666667
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 5.437417932333333
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 5.580415225666667
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 6.311898031333333
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 6.386462363
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.7649538436666665
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 5.634651462666667
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 5.636152737333333
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 6.246859051333334
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 6.308644552333333
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 5.821143913666667
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 6.377040150333333
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.878733251333333
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 6.291828669333333
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 6.688533265333334
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.958325964
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 6.173313059333334
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.805796449333333
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 6.180056026666667
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 5.938441350000001
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 5.9951168489999995
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 6.262372271

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.15684
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.130596499999999
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.1721094999999995
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.8910125
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.0100415
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.9645215
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.169718
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.028708
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.140918
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.0617
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.9521125
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.058279000000001
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.04492
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.114602
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.028957
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.158569
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.9345835000000005
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.192444500000001
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.097261
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.094307499999999
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.908732499999999
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.1195625
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.137119
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.040611

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 168.4189
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 138.67015

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 469.1305667033334
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 448.50257489666666
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1456.38792063
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 153.38951733000002
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 380.14804906
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 308.8464238466667
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 384.22701766366663
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 325.9441425466667
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 428.95104656333336
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 576.4292747133333
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 377.4001998666667
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 599.50167238
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 608.2413372299999
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 150.16442576666665

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.693808885333333
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.7444391249999995
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 5.912921007666667
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 5.437417932333333
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 5.580415225666667
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 6.311898031333333
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 6.386462363
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.7649538436666665
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 5.634651462666667
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 5.636152737333333
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 6.246859051333334
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 6.308644552333333
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 5.821143913666667
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 6.377040150333333
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.878733251333333
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 6.291828669333333
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 6.688533265333334
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.958325964
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 6.173313059333334
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.805796449333333
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 6.180056026666667
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 5.938441350000001
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 5.9951168489999995
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 6.262372271
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 469.1305667033334
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 448.50257489666666
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1456.38792063
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 153.38951733000002
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 380.14804906
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 308.8464238466667
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 384.22701766366663
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 325.9441425466667
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 428.95104656333336
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 576.4292747133333
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 377.4001998666667
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 599.50167238
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 608.2413372299999
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 150.16442576666665

ID GSE58803
Title Transcript Profiling of Periaqueductal Gray in Response to Electroacupuncture on Rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1419812 2Hz_HR_1h_PAG1 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG 0.917051459
GSM1419813 2Hz_HR_1h_PAG2 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG 0.56108757
GSM1419814 2Hz_HR_1h_PAG3 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h; strain: Sprague-Dawley treatment: control tissue: PAG 0.0
GSM1419815 2Hz_HR_1h_PAG4 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG 1.064708536
GSM1419816 2Hz_HR_1h_PAG5 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG -0.317503741
GSM1419817 2Hz_NR_1h_PAG1 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG 0.582419823
GSM1419818 2Hz_NR_1h_PAG2 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG 1.420825124
GSM1419819 2Hz_NR_1h_PAG3 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG 0.457181302
GSM1419820 2Hz_NR_1h_PAG4 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG 0.207422706
GSM1419821 100Hz_HR_1h_PAG1 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG 0.0
GSM1419822 100Hz_HR_1h_PAG2 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG 0.104739714
GSM1419823 100Hz_HR_1h_PAG3 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG 0.0
GSM1419824 100Hz_HR_1h_PAG4 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG 0.0
GSM1419825 100Hz_HR_1h_PAG5 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG 0.294353376
GSM1419826 100Hz_NR_1h_PAG1 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h; strain: Sprague-Dawley treatment: control tissue: PAG 0.0
GSM1419827 100Hz_NR_1h_PAG2 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h; strain: Sprague-Dawley treatment: control tissue: PAG 0.0
GSM1419828 100Hz_NR_1h_PAG3 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h; strain: Sprague-Dawley treatment: control tissue: PAG 1.355697356
GSM1419829 100Hz_NR_1h_PAG4 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG 0.120035863
GSM1419830 100Hz_NR_1h_PAG5 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG 0.719128571
GSM1419831 2Hz_HR_24h_PAG1 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG 0.99570881
GSM1419832 2Hz_HR_24h_PAG2 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG 1.140775693
GSM1419833 2Hz_HR_24h_PAG3 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h; strain: Sprague-Dawley treatment: control tissue: PAG 1.325399969
GSM1419834 2Hz_HR_24h_PAG4 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG 0.0
GSM1419835 2Hz_HR_24h_PAG5 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG -0.184382098
GSM1419836 2Hz_NR_24h_PAG1 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG 0.417893346
GSM1419837 2Hz_NR_24h_PAG2 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG 0.223695181
GSM1419838 2Hz_NR_24h_PAG3 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG 2.478563389
GSM1419839 2Hz_NR_24h_PAG4 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG -0.14730801
GSM1419840 2Hz_NR_24h_PAG5 rat strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG -0.752119268
GSM1419841 100Hz_HR_24h_PAG1 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG 0.370874525
GSM1419842 100Hz_HR_24h_PAG2 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG 0.433411082
GSM1419843 100Hz_HR_24h_PAG3 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG -0.140152777
GSM1419844 100Hz_HR_24h_PAG4 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG -4.318648581
GSM1419845 100Hz_HR_24h_PAG5 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG 0.391547277
GSM1419846 100Hz_NR_24h_PAG1 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG 0.049047725
GSM1419847 100Hz_NR_24h_PAG2 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG 0.008668254
GSM1419848 100Hz_NR_24h_PAG3 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG 0.402303685
GSM1419849 100Hz_NR_24h_PAG4 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG 0.42224394
GSM1419850 100Hz_NR_24h_PAG5 rat strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG 0.711078759

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 136.3
GSM5084 Control 2 115.95
GSM5085 Control 3 81.19999999999999
GSM5086 Control 4 131.1
GSM5087 Control 5 127.225
GSM5090 Control 6 132.1
GSM5105 Control 7 111.07499999999999
GSM5106 Control 8 111.725
GSM5107 Control 9 124.525
GSM5108 Halothane 10 exposure-1 112.275
GSM5109 Halothane 10 exposures-2 107.375
GSM5110 Halothane 10 exposures-3 106.35
GSM5111 Halothane 5 exposures-1 89.6
GSM5112 Halothane 5 exposures-2 137.05
GSM5113 Halothane 5 exposures-3 101.975
GSM5114 Isoflurane 10 exposures-1 84.975
GSM5115 Isoflurane 10 exposures-2 98.15
GSM5116 Isoflurane 10 exposures-3 95.32499999999999
GSM5117 Isoflurane 5 exposures-1 120.82499999999999
GSM5118 Isoflurane 5 exposures-2 95.30000000000001
GSM5119 Isoflurane 5 exposures-3 113.80000000000001
GSM11379 Control 10 131.6
GSM11380 Control 11 113.69999999999999
GSM11381 Control 12 121.8

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 23.153822333333334
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 35.023716666666665